Alice T. Shaw, MD, PhD, discusses the challenge of resistance mechanisms in the treatment of patients with non–small cell lung cancer whose tumors harbor ALK rearrangements.
Original Article: Leading ALK Researcher Tackles Resistance Challenge in NSCLC